Pacira BioSciences, Inc. (PCRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.15B |
| Enterprise Value | 1.45B |
| P/E Ratio | 74.84 |
| PEG Ratio | 1.15 |
| Price/Sales Ratio | 1.39 |
| Price/Book Ratio | 1.55 |
| Enterprise/Revenue | 1.67 |
| Enterprise/EBITDA | 10.83 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 726.41M |
| Revenue/Share | 18.91 |
| Gross Profit | 576.66M |
| EBITDA | 122.5M |
| Net Income | 7.03M |
| Diluted EPS | 0.16 |
Balance Sheet
| Total Cash | 251.03M |
| Total Cash/Share | 6.36 |
| Total Debt | 412.12M |
| Total Debt/Equity | 0.61 |
| Current Ratio | 5.04 |
| Book Value Per Share | 17.03 |
Price History
| 52-Week Change | -0.38 |
| 52-Week High | 27.66 |
| 52-Week Low | 18.8 |
| Moving Average 50 Days | 25.39 |
| Moving Average 200 Days | 23.81 |
Statistics
| Average Volume | 563,943 |
| Shares Outstanding | 39.34M |
| % Held by Institutions | 116.35 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
